Join us

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

COST Rules

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Search
Close this search box.
immuno-model symbol

Report on the outcomes of a Short-Term Scientific Mission

Report on the outcomes of a Short-Term Scientific Mission

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Action number: CA21135
Grantee name:
Tina Kolenc Milavec

Dissemination: During my 2-months long stay at the University Medical Center in Amsterdam, in the group of Febe van Maldegem, PhD, I learnt all about the Imaging mass cytometry (IMC). This novel technique enables us to determine spatial characteristics of a tissue and observe interactions between cells. I was using IMC to determine changes in the interactions within the glioblastoma microenvironment, which arise from applying treatment (radiotherapy and/or chemotherapy) to glioblastoma organoids. Understanding how cell interactions change after therapy will hopefully help us to unveil the mechanisms underlying therapy resistance.  

Tina Kolenc Milavec (left) and PhD student Sofie Koomen (right) trying to prepare organoids from the lung cancer tissue we obtained from a patient after surgery.

Me (Tina) in the laboratory, doing staining of FPPA-fixed glioblastoma tissue slices with the antibody mix for IMC analysis.

Me (left) and Sofie Koomen (right) at the Spring conference of the Dutch Society for immunology (NVVI) in Tiel, Netherlands. I sure learnt a lot of new things about immunology.

Short news/reports about the STSM were also posted on Instagram and LinkedIn.

Latest Updates

📅 Date: 31st August 2024📍 Location: Dublin, Ireland (In-person Event)🔬 Immunotherapies: charting a course from the lab to the clinic Join us for our next Workshop focusing on the current pre-clinical and clinical...
Job title: Postdoctoral Scientist- Cellular and Molecular Oncoimmunology As part of the National Plan for Recovery and Resilience (Piano Nazionale di Ripresa e Resilienza, PNRR), IRCCS Istituto Clinico Humanitas has started...
3rd IMMUNO-model webinar entitled “Mathematical Oncology” was streamed live on the ZOOM platform on June 25th, 2024 at 5.00 pm CET. The webinar consisted of two presentations and a question...
This event took place in Bratislava, Slovenia from the 13th and 15th of May 2024. The Annual Meeting workshop on “pre-clinical Models to the search for biomarkers in Immuno Oncology”...
IMSAVAR Project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies
We are pleased to invite you to the 2nd IMMUNO- model webinar entitled imSAVAR project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies. The webinar consists of two...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

COST Rules

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter